If you're looking for another Lavo Life Sciences, Genesis Therapeutics could be a good fit. Genesis uses an AI-based platform called GEMS that accelerates the discovery of new medicines by identifying novel protein targets and unexplored chemical space. The platform uses deep learning and molecular simulations to predict properties and generate molecules, allowing for more efficient design of highly potent and selective small molecule drugs.
Another alternative is JADBio, a no-code machine learning platform that automates biomarker discovery and interpretation. It can handle multi-omics data and includes tools like AutoML and feature interpretation that could be useful for drug discovery researchers. JADBio is particularly suited to investigating a variety of conditions, including cancer and metabolic disease, so it could be a good tool for early biomarker discovery and disease monitoring.